The management of recurrent &hernia in patients who have had previous saphettous vein bypass graft surgery poses a serious, difficult woblem. Recurrent ischemia occurs not ottly because of &t&ion of the saphenous vein @atIs hut also hacause of progression of coronary artery disease in the native comaary arteries. The attrition rate is 15% to 20% duing the 1st year after opmdion; between I and 6 years afteropcratiw. it is 1% to Z%/year and between 6 to IO years atIer surgery the rate is 4%/year (l-8). By 5 years, about 45% of the gratts are occluded (3.7). progression of native coronary artery disease occurs in appmximately 5% of the Tbziadwdbigbmska&&n(ea~pr&km.
Fipre I. Bisiologic crow section of a ')_month old saphenous vein bypass graft sboviog severe lun,cn narrowing due IO cow centric intilnal tbtcketig t-) consisting offibmcdlagmm~s tissue. Elaslic-van Giesca stain X25, w&wed by 29%.
of disease" in the bypass graft may have cxp4ained the high RtbwSmlyofaQbewm-9nns.TbepathGtecumnce rate in graft stenosis. Since then, many studies physiologic mecbanismr underlying gr&? failure can arbiconcerning angioplasty of lesions in sapbenous vein grafts barfly lx distinguiabed into lhose occurring early. within I have been reported. yearandtateafteropcmtAlneachperiodoaeaswmesa In this article we review the reported data and diw~ss the speciticpredm&Mtpgthcgenc(iemechsaism,alumughMK indications and the initial and late results of angidasty of must bear in mind that the different pgthcdogic pmcesvs saphenous vein bypass grafts. We also briefly discuss the may occur in a cmUinuaus fashion and overlap in titw mle of new techniques including stems, directional tad (18, 19) . extractional mherectomy and laser angioplasty.
Oraft occIwdon early after opemtivn is usually associated
with acute thrombmis (18.19). possibly attributable to hafvesting and handI@ of the vein or to failure of surgical techaiqws at sites of anattomosis (20).
Fibmintimal hyperplasia is the dominant feature I to 12 months atIer opemt& (20-22). The ceils of fibmintimal hyprpksia resemble smooth muscle cells and sane cells may bwe a foamy cytopksmic appearance (21). Focally stewtic ksians pmdwed by this pacess appear panicukrly ameooMetodiktkfi.
In tbe late pos~opcr&e period, fibtintimal hytwpksia sclerotic lesions bzcome more frequat &.. I &I 2) (19). The tibmintimal ksion maduattv diminishes its celhdmitv. and the smooth mwk& & qiaced by 6bmus t&s& and the matrix is incresxd. With lime, there appears to be an increase in the number of foam ceils within the iatima. The devetopmert of athmwckmsis in ths s0rtowmnm-y vein grafts is an impnrmm factor in late g7afl stenosis and occlusion (z-32). The atbenwckrc.tk plnceos pmceeds to a Rug developed compkx athzosakm6c ptaque WI. 31, and rupture of the plaque leads to a superimposed thrombotic occlusion (23, 24) . The plaques are often large, tiagile and ukerated and the graft may show aneurysmal dilation (25, 26) .
There is still some controversy as to whether venousgraft atherosclerosis differs from coronary atherosclerosis. Some investigators (2X,29) suggest that vein graft lesioss contain more foam cells, end that they exhibit an intlammatory reaction with foreign body giant cells. This prowess uodermines the thickened intima, so that the fibrous cap is weakened (Fig. 4) (28) . One study (29) demonstrated laik of a fibrous cap. This thinning and weakening of the fibrous cap may explain the greater propensity of venous plaque rupture and thrombosis. The propensity of thrombus fom&m in vein grafts is enlarged because the lack of side branches. the l&diameter of vessels end consequently low flow velocities may contribute to platelet aggregation and thmmbus formation. These factors may explain the frequent occurrence of thrombotic complications or embolization of mate. riol during balloon angioplasty. However, other investigators (18,19.26,30-32) believe that atherosclerosis vein graft disease is not different from arterial atherosclerosis.
Immediate rw~lts of nnglopIPrty for arphenous venom bypass grafts. Ford et al. (33) repotted a small series of seven patients of whom six underwent successful dilation. Since then, many centers have reported their initial results of angioplasty d saphenous veingrafts. Only the updated latest reports for eacS center are presented in Table I .
The initial succe~r rate varies from 75% to 9446, with a combined overall success rate of 88%. The major complication rate is low, with a procedure-related death rate of <I%, a myocardial infarction rate of ==4% and a need for urgent coronary bypass graft wrgery of <2%. The remarkably low tendency to abrupt occlusion and the relatively hii success rate are p&ably due to the abseoce of side branches and tortuosity. The risk of embolization of friable, thrombotic material into the native circulation is <3%. Embolism osoallyoccurrduringattemptedangioplasty in oldergrafts, with loog diseased segments containing friabk, thrombotic lerions. The initial success rate depends on the site of dilation (TaMe 2). The werall combimd initial results of dilation of the proximal site is 87%. of the gmll body 94% and of the distal site !XI%. These rates appear to be similar except for a sliitly lower success rate for dilation a1 rhe proximal site. The high success rate and low complication rate reikct the careful selection of patients. DifFKult lesions with potential hii risk, such as loog disc lesions or ulcerated, tbnrmbolic, friaMe lesions, were probably excluded from these series.
Tabk 2. lnitid Succew Rale of Dilation of Saphemrus Vein Grafts et Diflerent Sites

Tabk 3. Restenosis Afler Successful Angiopksty of Saphenous Venous Gmhs
Reatenosis after suerraful dihtton of @woous vein grafts. The resteoosis rate (defined as >50% lumen diameter narrowing in the majority of the reported studies) after initially successful aogioplasty depeods highly on the site of dilation witbin the graft (Table 3) . O&l or very proximal graft lesions tend to have a very bii resteoosis rate (56% on average). The restenosis rate of the body of the graR is 52% and the restmosis rate in the distal, aoastoowtic pat of the graft is 28%. The overall combined resteoosis rate is 42%. These data probably overestimate the tree incidence of resteoosis because oat all asymptomatic patients are restudied. The angiographic completeness of follow-up varied from 56% to 100% in the reported studies (Table 3) .
In native comoary tier&, the restenosis pmcess takes place in the majority of the patients withio 6 months atter attgioplasty. It is oat koown whether the restenosis process in veooos bypass g&s is similar, but data repened by Douglas et al. (52) suggest that the interval is longer. lo follow-up studies of.599 patients with successfol angioplasty. restenosis was foood in 32% of dilated lesions within 6 months of operation in 43% by 6 months to I year, in 61% by lto5yearsaodin64%after5years. (Table 4) pmmpt revascttlarization does limit the damage (59). The time between the onset of &hernia and revascolarization determines the outcome (60). The ischemic period during reoperation is considerably prolonged because immediate access to the heart is hampered by the fibrosis of the previous operation, which may require considerable time to dissect free the heart. This inevitable delay limits the potential of revascohuization to reduce myocardial damage. If possible, bailout techniques, such as use of autoperfusion catheters, should aMys be used in these situations. Stent implantation for threatened closure has produced satisfactory results (61).
This expected time delay should bp considered when counseling a patient. It would be prudent to refer a patient for reoperation if, for instr ICC, abrupt closure of a lesion would lead to acute heart failure due to the large area of myocardium at risk.
New interventhmal technlqoes for treatment of sapbenaua vein bypass graL. Srenr imploaration. The intmcoronary stent was the first of the new interventional techniques to be applied in bypass ~mft an&4asty. Shortly after the introduction into the native coronary artery system, stents were also imolaoted in brass aratls (Fin. 6) (62-64). The immediate &ogmphic.&d &~pk&&n 's&e& rate is extremely high (295%. . However, early experience was associated with an unacceptable high incidence of subacute thrombosis and serious bleeding cornplications. Increased operator experience and meticulous amicoagolation resulted in a substantial decrease in complications (64-66). UnfortunateIy, the incideoce of restewsis do-as not seem to have been reduced (Table 6 ). One detailed study ML restenoais after Wall stent implantation in venous bypass grafts reports ao incidence of resteoosis of 3% according to the 5G% diametu stenosis criterion (67). me resteo&s rate was 35% after implantation of a flexible coil (61) and <ZS% after implantation of a Palmaz-khatz stem (68). Restenosis occurred more freaoentlv after Wallstent &hntatim in bypass g&s than in &eoteh native comwy arteries (69). The rates were aim&r in graft8 aad native arteries after Palmaz-Schatz stent implantation (68). Whether the better results obtabwd with the Palmae-Schata were due to the more favorable features of this steot or to improved &mwdural phmmacologic management or dif. ferent patient selection is unknown.
The lottgt~ clinical follow-up results of Wallstent implantation in bypass grafts collected from 145 Patients of six European centers is shown in Figure 7 (67). The actuarial event-free aorvival (freedom from death, myowdii infarrtion, bypars surgery or aogioplas(y) for bypass gmft patleots was 37% at 20 months with an overall mmiality rate of%. About 30% of the adverse events were uorelated to the steoted lesion and were doe to wonening of dilferent ksioor or to development of new ksions (64,67) .
Afkrecfom~:
direcfional and extractional. The USC of dhzctlonal atherectomy in aapheacus venooa bypass grafts was feasible and sucwsfol in >9C% of oatlents (Table 7) @5,70,71). The complication rate wps ac;ep(able; but o& can imagine that the use of such a bulky device in case of friable, thrombutic lesions easily embolizes material. F&m-inary data suggest that the restenosis rate is also high.
Extraetionai atherectomy of vein graft lesions was succeatitl in 69% of patients (Table 7 ) (72). The complication rate was low and the restenosis rate WI 53%. It is conceivable that the use of this device in vein grafts containing much material is safe and is associated with a higher SUECCSS rate and decreased risk of embolization due to the suction, extraction and removal of material with this device, although embolization occurred in 3.5% of oatients.
Excimer laser angiophty. In-an initiaI experience includina 22.5 oatients ( Table 7L A .wcce~s rate of 97% was achieved in lesions in older saphenous vein grafts; however, the preliminary repmed nstenosis rate of 61% was rather hii.
Cmdmlaas. Currently sufficient data are lacking to establish the merits of reoperation and balloon angiaplaay to treat obsIrttctions in venous bypass g&s. The published compaml of dbTcrences in"pa~iett~selection, and tirm conclusionP about the supcriotity of one treatment above the other should not be drawn. A review of the published data indicates that in selected patients ballooo an&&sty may be the ptefetred strategy and, in case of itwembility, it is the only strategy.
A&o&w of twocclusive obstructions in vetate bypass @Is is safe and the success rate is high. The high restenosis rate adversely z&cts the lottgwm molts. The kttmediate arid long-term results of aogioplasty for chronic total aclusion in old grafts arr poor.
Patiett~s cottsidend for saphenoos vein graft angioplasty may be claG6ed into three groups according to expected early and late outcome: I) those with zm initial high success, low procedural risk and low rateoasis rate; 2) those with an initial high success but hi pmeedmal risk and moderate to high restenosis rate; and 3) thase with a low success. hi& risk and high rewwsis rate (Table 8) .
New techniques have shown to be pomising and stent placement, in particular, may be useful to "tags ftiable material. However, definite conclusions ;amcemir&he merits of new techniques must await tiaalization of ongoing randomized trials. Balloon aeioplzty is a palliative pzoce. due, not a long-temt solution in patients ptwicusly operated on, who oflen present with late-stage cormtaw artery disease. The hiti restettosis rate is a serious limitation of balloon angiopl&y.
